New Drug For Kidney Disease: FDA Approved New Medication for CKD
CKD is a very critical disease, and there are only a few practical ways to tackle it. In 2022, medical science has provided new hope to patients with Chronic Kidney Disorder (CKD). Researchers have discovered a new treatment that is not only effective but also approved by the FDA. This advancement is one of the most promising treatments for CKD. We have discussed this new treatment for CKD in detail, so make sure you don't miss out!
Chronic Kidney Disorder is a condition in which the kidney's functioning degrades over time. If not treated in time, it can lead to kidney failure.
As per the National Kidney Foundation, more than 10% of the world's population suffers from chronic kidney disorder. Millions of people die annually due to not having access to proper treatment. Studies state that CKD ranks 18th among diseases for the cause of the total number of deaths per year.
Every year, around 20 million people need a kidney transplant or dialysis treatment to live, yet less than 2 million get access to such treatments. Of these 2 million, only 20% of the patients are from developing countries.
It is estimated that in developing countries like India and China, the kidney failure rate will increase proportionally with the increase in the elderly population. In such countries, treating CKD becomes a financial burden, and thousands of people die due to the inability to treat kidney failure.
From the above-given information, the severity of chronic kidney disorder (CKD) can be understood, and why the new drug for treating CKD is so essential.
In 2021, the FDA approved Farxiga (dapagliflozin) to slow down the process of kidney degradation. Forxiga® (dapagliflozin) was added to the Australian Pharmaceutical Benefits Scheme (PBS) on September 1, 2022, with the goal of lowering the risk of progressive deterioration in kidney function in people with proteinuric chronic kidney disease who matched the PBS listing's specific requirements.
Let's take a closer look at this new treatment.
What is the New FDA Approved Treatment for CKD?
- Dapagliflozin is an oral drug. It aims to slow down the process of kidney degradation. It does so by absorbing glucose from the kidneys into our circulatory system.
- Dapagliflozin is the latest drug to be added to the PBS for treating CKD in the last 20 years.
- It is also the first medicine approved for treating CKD involving the leak of protein in the urine to many patients.
- It is advised to take Dapagliflozin as a second-line treatment concurrently with other drugs.
A study shows that when dapagliflozin is added to standard treatment, people with CKD (with or without type 2 diabetes) have a lower risk of CKD development. International guidelines and KDIGOz recommend dapagliflozin as a standard treatment for CKD (with or without type 2 diabetes).
Are there any side effects associated with Farxiga (dapagliflozin)?
Like any other medicine, this new drug has its side effects. No matter how minimal, one should be aware of the medicine's adverse effects. Below we have presented you with the side effects of this new drug, so pay attention!
- It may cause urinary tract infections in some cases.
- It may lower glucose levels in your body.
- Temporarily reduced kidney functions
- Euglycaemic ketoacidosis
Note: The chances of facing side effects are much higher among patients with type 2 diabetes than others.
What should the patients know?
- After taking Dapagliflozin, the patient's blood pressure may drop, and they can feel dizzy. They should rest for a few hours after consuming the drug.
- Urine tests will show the presence of glucose during the treatment period.
- It is suggested to drink enough water to control dehydration of their body.
- Consuming Dapagliflozin can increase the chances of genital infections. It is suggested to maintain personal hygiene and seek medical attention if needed.
- Dapagliflozin can be consumed pre and post-meal.
Who are not eligible for this new CKD treatment?
- Patients with polycystic kidney disease
- Patients with a recent history of immunosuppressive therapy
- Patients with serious hepatic impairment
- Patients less than 18 years of age
- Patients with known hypersensitivity or allergies to any of the ingredients
- Patients with type 1 diabetes
- Patients with diabetic ketoacidosis
- Women during pregnancy. Also, it is suggested to discontinue the treatment if pregnancy is detected during the treatment.
- Women who are breastfeeding
Question and Answers (15)
Contrast Enhanced Computed Tomography of the whole abdomen showing moderate hypatomegaly with coarse attentuation, edematous GB mild dilated portal vein,splenomegaly,diverticulituis in sigmoid colon. Crystitis. My brother suresh kumar's report has been admitted in Maharaja Agrasain Hospital, Punjabi Bagh and the doctor has recommended us for a second opinion. Kindly advise / suggest next course of action if possible.
I am 50years.i am dialysis patient.now my HCV report is positive.now I'm very weak, can't stand properly.what i eat then vomit after few minutes.my RNA titre report will get next Wednesday. Now what should i do?pressure is always fluctuating.i follow nephrologist prescription and take the medicines but now i become very incapable to do anything. Please suggest me.hepatologist of sskm suggested 1st collect the hepatitis c reports then visit him.
Pain in lower left side of stomach rest all parameters are normal E.g feel hungry normally, have normal bowel movement and normal urination.I was taking Cyclopam for the pain but now it's almost a month. Got my test report for Serum Creatinine level value is 0.74 mg/dlX
You need to get a USG of Abdomen done and a urine routine examination. For detailed information You need to consult Best Nephrologist in Thane.
From last one week doctor, i am suffering a lot due to stone
If the problem is severe you should consult a best Urologist in India to get things cleared.
Sir now a day my father suffering from chronic kidney diseases last stage before six months ago. And he takes some medicines like nodosis 500 mg thrice daily. But I am not satisfied then what can i do please suggest me.
Chronic kidney disease is usually a progressive disease and tends to progress over time. But inspite of having it patient can be maintained in a reasonably good health with proper medication, diet and routine Nephrologist's consultation. I request you to reach to a nephrologist near you for treatment optimisation.
New Drug For Kidney Disease 2022 - FDA Approved New Medication for HRSKidney failure happens due to many other diseases. One such deadly disease is hepatorenal syndrome. This liver disease worsens kidney functions at a rapid rate. Terlipressin, sold under the brand name Terlivaz, became the world’s first FDA-approved drug to improve kidney function in adults with HRS. Read to the end to know more about the new kidney disease drug in detail.
12 Best Kidney Specialist in the World- Updated 2022Nephrology deals with kidney medicine and is a subspecialty of internal medicine. Nephrology is the term given to all the problems related to the kidney, and it deals with all the aspects of the kidney. The human body consists of two kidneys, which have a lot of work to do 24 hours a day just because they play a vital role in purifying the water and liquid content in the body, which helps our body maintain temperature and diet. Let's check out who the 12 best nephrologists in the world are. Find out more about them below.
New IgA Nephropathy treatment- First FDA approved medicine for rare kidney diseaseIgA Nephropathy is a kidney disorder that happens as a result of immunoglobulin formation that leads to inflammation of the tissues in the kidney. IgA nephropathy is a very common kidney disorder, and because of a delay in treatment, it may lead to end-stage kidney disease. In this article, we bring you all you need regarding the new IgA nephropathy treatment. Continue reading along to find out!